Lea J. Mertens

1.2k total citations
23 papers, 738 citations indexed

About

Lea J. Mertens is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lea J. Mertens has authored 23 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Clinical Psychology, 14 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lea J. Mertens's work include Psychedelics and Drug Studies (21 papers), Chemical synthesis and alkaloids (14 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Lea J. Mertens is often cited by papers focused on Psychedelics and Drug Studies (21 papers), Chemical synthesis and alkaloids (14 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Lea J. Mertens collaborates with scholars based in Germany, United Kingdom and United States. Lea J. Mertens's co-authors include Leor Roseman, Max Wolff, Robin Carhart‐Harris, David Nutt, Hannes Kettner, Gerhard Gründer, Ricarda Evens, Katrin H. Preller, Henrik Jungaberle and Lysia Demetriou and has published in prestigious journals such as Psychological Review, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Lea J. Mertens

20 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea J. Mertens Germany 12 674 399 303 70 68 23 738
Richard J. Zeifman Canada 18 739 1.1× 374 0.9× 280 0.9× 61 0.9× 84 1.2× 43 806
Henrik Jungaberle Germany 16 664 1.0× 358 0.9× 219 0.7× 78 1.1× 115 1.7× 36 857
Richard E. Daws United Kingdom 9 519 0.8× 295 0.7× 285 0.9× 50 0.7× 65 1.0× 17 739
Joshua Woolley United States 11 560 0.8× 390 1.0× 211 0.7× 68 1.0× 54 0.8× 22 609
Laura Kärtner United Kingdom 7 508 0.8× 335 0.8× 195 0.6× 58 0.8× 33 0.5× 10 546
Jacob S. Aday United States 15 877 1.3× 541 1.4× 328 1.1× 73 1.0× 49 0.7× 37 988
Dominique Holstein Switzerland 5 514 0.8× 310 0.8× 281 0.9× 49 0.7× 42 0.6× 5 637
Matthew P. Bradstreet United States 6 631 0.9× 407 1.0× 229 0.8× 80 1.1× 55 0.8× 9 755
Collin Reiff United States 8 499 0.7× 240 0.6× 195 0.6× 51 0.7× 137 2.0× 11 653
Thomas Cody Swift United States 6 603 0.9× 351 0.9× 178 0.6× 68 1.0× 45 0.7× 6 612

Countries citing papers authored by Lea J. Mertens

Since Specialization
Citations

This map shows the geographic impact of Lea J. Mertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea J. Mertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea J. Mertens more than expected).

Fields of papers citing papers by Lea J. Mertens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea J. Mertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea J. Mertens. The network helps show where Lea J. Mertens may publish in the future.

Co-authorship network of co-authors of Lea J. Mertens

This figure shows the co-authorship network connecting the top 25 collaborators of Lea J. Mertens. A scholar is included among the top collaborators of Lea J. Mertens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea J. Mertens. Lea J. Mertens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gründer, Gerhard, et al.. (2025). Psychedelics: The pathway to implementation in the European healthcare systems. European Neuropsychopharmacology. 102. 41–48.
2.
Gründer, Gerhard, et al.. (2025). Compassionate use of psilocybin for treatment-resistant depression in Germany. The Lancet Psychiatry. 13(2). 91–93. 1 indexed citations
3.
Wolff, Max, Lea J. Mertens, Sergio Murgui, et al.. (2025). Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe’s general change mechanisms.. Psychological Review. 132(6). 1467–1492. 2 indexed citations
4.
Mertens, Lea J., et al.. (2024). Psilocybin as a disease-modifying drug—a salutogenic approach in psychiatry. Deutsches Ärzteblatt international. 121(26). 868–874.
5.
Mertens, Lea J., et al.. (2024). Psychotherapeutisches Setting und Integration bei psychedelikaassistierter Therapie. Nervenheilkunde. 43(5). 244–250. 1 indexed citations
6.
Wolff, Max, Ricarda Evens, Lea J. Mertens, et al.. (2024). Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ). Journal of Psychopharmacology. 38(5). 432–457. 16 indexed citations
7.
Gründer, Gerhard, et al.. (2024). Pharmakotherapie, Psychotherapie oder „Superplacebos“?. 69(2). 92–97. 2 indexed citations
8.
Herwig, Uwe, et al.. (2023). Psychedelika in der Psychiatrie – Entwicklungen und die Stellung in Deutschland. Fortschritte der Neurologie · Psychiatrie. 91(07/08). 311–318. 4 indexed citations
9.
Gründer, Gerhard, et al.. (2023). Treatment with psychedelics is psychotherapy: beyond reductionism. The Lancet Psychiatry. 11(3). 231–236. 54 indexed citations
10.
Kärtner, Laura, et al.. (2023). Psychedelika in Psychiatrie und Psychotherapie - Trend oder Therapie?. 24(6). 30–35. 1 indexed citations
11.
Watts, Rosalind, Hannes Kettner, Sam Gandy, et al.. (2022). The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Psychopharmacology. 239(11). 3461–3483. 89 indexed citations
12.
Gründer, Gerhard, et al.. (2022). Sind Psychedelika schnell wirksame Antidepressiva?. Der Nervenarzt. 93(3). 254–262. 6 indexed citations
13.
Mertens, Lea J., Michael Koslowski, Felix Betzler, et al.. (2022). Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design. Neuroscience Applied. 1. 100104–100104. 24 indexed citations
14.
Kettner, Hannes, Lea J. Mertens, Leor Roseman, et al.. (2022). Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. Journal of Psychopharmacology. 36(1). 31–45. 77 indexed citations
15.
Wolff, Max, Ricarda Evens, Lea J. Mertens, et al.. (2020). Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance. Frontiers in Psychiatry. 11. 5–5. 94 indexed citations
16.
Mertens, Lea J., Matthew B. Wall, Leor Roseman, et al.. (2020). Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. Journal of Psychopharmacology. 34(2). 167–180. 130 indexed citations
17.
Zeifman, Richard J., et al.. (2020). Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Frontiers in Psychiatry. 11. 782–782. 75 indexed citations
18.
Meinhardt, Marcus W., et al.. (2020). Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. Neuropsychopharmacology. 45(8). 1316–1322. 48 indexed citations
19.
Mertens, Lea J., Juri‐Alexander Witt, & Christoph Helmstaedter. (2018). Affective and behavioral dysfunction under antiepileptic drugs in epilepsy: Development of a new drug-sensitive screening tool. Epilepsy & Behavior. 83. 175–180. 11 indexed citations
20.
Krause-Utz, Annegret, et al.. (2018). Childhood Maltreatment, Borderline Personality Features, and Coping as Predictors of Intimate Partner Violence. Journal of Interpersonal Violence. 36(13-14). 6693–6721. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. Zeifman Breakdown of academic impact, for papers by Henrik Jungaberle Breakdown of academic impact, for papers by Richard E. Daws Breakdown of academic impact, for papers by Joshua Woolley Breakdown of academic impact, for papers by Laura Kärtner Breakdown of academic impact, for papers by Jacob S. Aday Breakdown of academic impact, for papers by Dominique Holstein Breakdown of academic impact, for papers by Matthew P. Bradstreet Breakdown of academic impact, for papers by Collin Reiff Breakdown of academic impact, for papers by Thomas Cody Swift
Rankless by CCL
2026